Skip to main content
Admissions guidance, study banks, and career tools — get started on Shalyam
Research News

10-Cent Heart Drug Cuts Hospitalizations by 25%

Mayur Tembhare
  1. Over 500,000 people in the Netherlands have heart failure.

  2. A low dose of digoxin reduced hospital admissions for heart failure by 25%.

  3. Digoxin has been used for centuries and costs less than ten cents per day.

  4. The researchers combined data from two earlier studies with their own findings to create a larger group of patients.

10-Cent Heart Drug Cuts Hospitalizations by 25%

Topic: Health

Three studies led by Dutch cardiologists show that a low dose of digoxin can reduce hospitalizations and deaths in people with heart failure. The inexpensive medication has been used for centuries and costs less than ten cents per day.

Heart failure is a serious health problem affecting over 500,000 people in the Netherlands. It occurs when the heart cannot pump blood effectively, leading to shortness of breath, fatigue, and repeated hospitalizations.

Researchers at UMCG led by cardiologists Dirk Jan van Veldhuisen, Kevin Damman, and Peter van der Meer conducted three studies on digoxin's effectiveness in treating heart failure. They found that a low dose of the medication reduced hospital admissions for heart failure by 25% and deaths from cardiovascular disease.

The researchers combined data from two earlier studies with their own findings to create a larger group of patients. This meta-analysis showed that digoxin produced a significant benefit, even when patients were already taking standard heart failure medications.

A third study followed participants who had been assigned either digoxin or a placebo. Those who stopped taking digoxin experienced more problems during the first six weeks compared to those who never took the drug.

Why It Matters

This discovery could lead to changes in heart failure treatment guidelines, making this inexpensive medication available to many more patients in India and worldwide. Heart failure is a growing health problem in India, affecting millions of people.

Key Facts

  • Over 500,000 people in the Netherlands have heart failure.
  • A low dose of digoxin reduced hospital admissions for heart failure by 25%.
  • Digoxin has been used for centuries and costs less than ten cents per day.
  • The researchers combined data from two earlier studies with their own findings to create a larger group of patients.
  • Those who stopped taking digoxin experienced more problems during the first six weeks compared to those who never took the drug.

Key Terms

Digoxin
A medication that has been used for centuries to treat heart failure, costing less than ten cents per day.

Implications

This discovery could lead to changes in heart failure treatment guidelines, making this inexpensive medication available to many more patients in India and worldwide. Heart failure is a growing health problem in India, affecting millions of people.

Source: https://www.sciencedaily.com/releases/2026/08/260814235858.htm

Journal reference:

  1. D. J. van Veldhuisen, M. Rienstra, A. Mosterd, M. Alings, A. A. Voors, K. Damman, A. D. I. van Asselt, M. L. Bouvy, J. Schaap, E. E. van der Wall, H. J. G. M. Crijns, D. J. Touw, P. A. M. Hoogslag, J. E. C. van de Swaluw, R. J. Schuurman, A. van der Sluis, O. Bondarenko, T. J. Römer, T. Oosterhof, G. L. Bartels, S. Koudstaal, P. A. Dijkmans, G. C. M. Linssen, I. Aksoy, H. G. R. Dorman, A. Schut, M. E. W. Hemels, R. G. Tieleman, D. J. A. Lok, I. C. D. Westendorp, M. A. T. Vijver, G. H. D. Voordes, A. H. de Vos, E. L. Maas-Soer, D. Postmus, G. Lunter, J. G. P. Tijssen, P. van der Meer. Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial. Nature Medicine, 2026; 32 (7): 2647 DOI: 10.1038/s41591-026-04406-6
  2. Kevin Damman, Dirk J. van Veldhuisen, Johann Bauersachs, Michiel Rienstra, Arend Mosterd, Adriaan A. Voors, Geert H. D. Voordes, Udo Bavendiek, Peter van der Meer. Efficacy and Safety of Digitalis Glycosides in Heart Failure. JAMA, 2026; 335 (23): 2029 DOI: 10.1001/jama.2026.7886

Leave a comment

← All research

Get Exclusive Insights with Every Issue

Join Shalyam Newsletter

Stay ahead in education, research, and innovation—straight to your inbox.